Did you know that the Bridge Program, part of the Grayken Center for Treatment at South Shore Health has treated 1,765 people and performed 14,236 office visits since its inception? And, through the efforts of the nationally-sponsored, Weymouth-based HEAL (Helping End Addiction Long-term) Initiative...

South Shore Health continues to actively monitor the COVID-19 situation.

South Shore Health System, Inc. (“Applicant”) with a principal place of business at 55 Fogg Road, South Weymouth, MA 02190 intends to file a Notice of Determination of Need with the Massachusetts Department of Public Health for a change in service by South Shore Hospital (“SSH”). The project is for...

William Tollefsen, MD., M.Sc., MBA, FAEMS, has been appointed Vice Chair of Emergency Medicine and Urgent Care at South Shore Health. In addition to his current roles in Mobile Integrated Health and EMS, he will be responsible for providing the strategic and clinical leadership for all urgent care...

South Shore Health is applying for re-designation as a Magnet organization. Patients, staff, and interested parties are invited to provide comments.

Thirteen year old Tom Corbett is known among family and friends as a very kind and generous boy. On Thursday he brightened the lives of strangers as well. While making good on his promise to buy his cousin a stuffed animal at a Build a Bear store, he saw a New England Patriots-themed bear and had an...

South Shore Health has taken an additional step to protect the safety of our patients by setting up a COVID-19 testing site at Union Point, Weymouth. Patients who have COVID-19 symptoms and are deemed eligible for a sample collection and subsequent testing at an approved lab will be registered and...

South Shore Health’s pediatric emergency department has seen an uptick in incidences involving children who have become seriously ill after ingesting products THC edibles. Learn how to keep your kids safe.

With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.